Clinical Trial NCT05646524
Trial
NovelMed – NM8074 (NCT05646524)
Clinical trial ID
NCT05646524
Drug name
---
Company:
NovelMed
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Not yet recruiting
Start
11/2023
Substance
Monoclonal antibody
Research question
Treatment-naive patients, assesssment of safety, efficacy and immunogenicity in 2 dosing schemes
Delivery method of drug
---
Frequency
every 2 weeks
Clinical trial locations
tbd